Management of adverse events associated with encorafenib plus cetuximab in patients with BRAF V600E-mutant metastatic colorectal cancer (The BEACON CRC Study)

Authors
Category Primary study
JournalAnnals of oncology
Year 2020
This article has no abstract
Epistemonikos ID: 95de68d980ec0dc4327542f33ebde1c4c1f65aed
First added on: Feb 01, 2023